How to Help Your Patients Find Voquezna In Stock: A Provider's Guide

Prescribing Voquezna (vonoprazan) is one thing. Ensuring your patient actually gets it filled is another. As a gastroenterologist, internist, or primary care physician, you may be fielding calls from frustrated patients who can't find Voquezna at their local pharmacy. This guide walks through the most effective tactics to reduce the friction between prescription and pickup.

Understanding the Access Gap

Voquezna is not in an official FDA drug shortage, but patients frequently encounter access issues because:

• Many retail pharmacies do not stock it consistently (high cost, newer drug)

• Insurance prior authorization (PA) is often required before coverage is granted

• Step therapy policies require documented PPI failure at many payers

• No generic alternative exists, keeping cash prices very high without assistance

Proactive prescribing workflows dramatically reduce the number of patient callbacks.

Step 1: E-Prescribe to BlinkRx for Seamless Access

The single most effective intervention you can make when prescribing Voquezna is to direct the prescription to BlinkRx rather than a retail pharmacy. Phathom Pharmaceuticals' partnership with BlinkRx provides a managed fulfillment pathway:

• E-prescribe: Search "BlinkRx US Boise, Idaho" in your EMR's e-prescribing dropdown. This routes the Rx to BlinkRx's pharmacy network.

• Patient contact: BlinkRx reaches out to your patient via secure text link, verifies their identity and prescription, and checks insurance coverage.

• PA support: If prior authorization is needed, BlinkRx initiates and tracks the PA, reducing the burden on your practice.

• Savings application: BlinkRx automatically applies the Voquezna Savings Card for eligible commercially insured patients, getting their cost to as little as $25.

• Free home delivery: The medication ships directly to the patient, eliminating the need to find a retail pharmacy with stock.

Prescriber call: 1-844-759-0782. Website: voqueznapro.com/gerd/blinkrx.

Step 2: Anticipate Prior Authorization and Document Appropriately

Prior authorization is a near-universal barrier for Voquezna at most commercial and Medicare plans. You can dramatically accelerate approval by ensuring your note contains the right elements before the prescription is submitted:

• Endoscopic diagnosis: Document the endoscopic grade (LA Classification A–D). For Grade C/D, reference the PHALCON-EE trial demonstrating vonoprazan's superiority over lansoprazole.

• Prior PPI therapy: List PPIs tried, doses, duration, and reason for inadequate response. This satisfies step therapy requirements.

• H. pylori indication: For Triple/Dual Pak, document positive H. pylori testing method, suspected resistance profile (especially if community clarithromycin resistance >15%), and treatment history.

• Medical necessity statement: Briefly state why vonoprazan is medically necessary vs. continuing a PPI. A single sentence citing endoscopic grade and PPI failure history is often sufficient.

Step 3: Communicate the Savings Card at the Point of Prescribing

Many patients abandon their prescriptions when they see the sticker price of Voquezna at the pharmacy counter. Head this off by briefing patients at the time of prescribing:

• For commercially insured patients: The Voquezna Savings Card (voquezna.com/savings or 1-833-366-7149) can reduce cost to as little as $25/month. The card is available for 30, 60, or 90-day supplies.

• For uninsured or underinsured patients: GoodRx coupons reduce cash price to approximately $199; SingleCare to approximately $583. No formal patient assistance program has been announced.

• For Medicare/Medicaid patients: The Voquezna Savings Card is not available. Encourage these patients to compare Medicare Part D plan formularies. Discuss whether a PPI alternative may be more cost-effective for their situation.

Step 4: Direct Patients to medfinder If Using a Retail Pharmacy

If a patient prefers or needs to use a retail pharmacy, direct them to medfinder.com. medfinder calls pharmacies in the patient's area to check Voquezna inventory, then texts the results back — eliminating the time-consuming manual calling. This is especially helpful in rural areas where stocking may be inconsistent.

Step 5: Offer a PPI Bridge When Appropriate

For patients with active erosive esophagitis, interrupting acid suppression while waiting for Voquezna access can cause harm. If the expected delay exceeds 3–5 days, consider prescribing a bridge with a high-dose PPI (omeprazole 40 mg daily or esomeprazole 40 mg daily) and transitioning to vonoprazan when access is resolved. Document the bridge and intent to switch.

Practice Workflow Tip: Standardize Voquezna Prescribing

Consider building a standard workflow for your practice:

1. Always e-prescribe Voquezna to BlinkRx (not a retail pharmacy)

2. Ensure the note documents PPI history, endoscopic grade, and medical necessity

3. Hand patients a print-out with the Voquezna Savings Card info and medfinder.com

4. Follow up within 1 week to confirm the patient received the medication

The Bottom Line

Access barriers for Voquezna are real but solvable with the right workflow. E-prescribing via BlinkRx is the most efficient single step. For providers looking for additional patient access resources, visit medfinder.com/providers.